Details for New Drug Application (NDA): 017619
✉ Email this page to a colleague
The generic ingredient in LOTRIMIN is butenafine hydrochloride. There are two drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the butenafine hydrochloride profile page.
Summary for 017619
Tradename: | LOTRIMIN |
Applicant: | Schering Plough |
Ingredient: | clotrimazole |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 017619
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes |
Expired US Patents for NDA 017619
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Schering Plough | LOTRIMIN | clotrimazole | CREAM;TOPICAL | 017619-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription